Scientists reprogram Patients' own immune cells to fight advanced gynecologic cancers
NCT ID NCT05468307
Summary
This early-phase study tested a new treatment called GC203 TIL for advanced gynecologic cancers. Doctors took immune cells from patients' tumors, genetically modified them to be more powerful, grew large quantities, and infused them back into 26 patients who had run out of standard treatment options. The main goals were to check if this personalized cell therapy was safe and if it could shrink tumors or control cancer growth.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for TREATMENT SIDE EFFECTS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Shanghai Tenth People's Hospital
Shanghai, Shanghai Municipality, 200000, China
Conditions
Explore the condition pages connected to this study.